Xenon Pharmaceuticals, Inc. (XENE)
37.58
-0.44
(-1.16%)
USD |
NASDAQ |
Oct 05, 16:00
37.77
+0.19
(+0.51%)
After-Hours: 20:00
Xenon Pharmaceuticals Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2025 | -867.3% |
| December 31, 2024 | |
| September 30, 2024 | |
| June 30, 2024 | |
| March 31, 2024 | |
| December 31, 2023 | |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | -28.14K% |
| June 30, 2022 | -5.81K% |
| March 31, 2022 | -224.4% |
| December 31, 2021 | -684.1% |
| September 30, 2021 | -190.1% |
| June 30, 2021 | -996.8% |
| March 31, 2021 | -361.7% |
| December 31, 2020 | -239.3% |
| September 30, 2020 | -135.1% |
| June 30, 2020 | -1.31% |
| March 31, 2020 | -105.7% |
| December 31, 2019 | -341.7% |
| Date | Value |
|---|---|
| September 30, 2019 | -253.5% |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | -50.41K% |
| September 30, 2017 | -2.93K% |
| June 30, 2017 | -49.20K% |
| March 31, 2017 | -46.98K% |
| December 31, 2016 | -1.60K% |
| September 30, 2016 | -1.87K% |
| June 30, 2016 | -1.46K% |
| March 31, 2016 | -542.9% |
| December 31, 2015 | -122.0% |
| September 30, 2015 | -89.12% |
| June 30, 2015 | 28.87% |
| March 31, 2015 | -105.4% |
| December 31, 2014 | |
| September 30, 2014 | 27.25% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -46.97% |
| Return on Assets | -41.36% |
| Return on Invested Capital | -46.56% |
| Return on Net Operating Assets | -2.51K% |